XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Revenues
3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenues
Note 3. Revenues
Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):
Three Months Ended
March 31,
20232022
JAKAFI revenues, net$579,969 $544,464 
ICLUSIG revenues, net27,685 26,069 
PEMAZYRE revenues, net22,475 18,032 
MINJUVI revenues, net6,556 4,502 
OPZELURA revenues, net56,552 12,754 
Total product revenues, net693,237 605,821 
JAKAVI product royalty revenues76,692 70,867 
OLUMIANT product royalty revenues34,155 48,064 
TABRECTA product royalty revenues4,177 3,483 
PEMAZYRE product royalty revenues412 — 
Total product royalty revenues115,436 122,414 
Milestone and contract revenues— 5,000 
Total revenues$808,673 $733,235 
For further information on our revenue-generating contracts, refer to Note 7.